Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Enlivex Therapeutics Ltd
(ENLV)
NASDAQ
:ENLV
ENLV
Enlivex
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Download ENLV Report
Want to see ENLV full AI Analyst Report?
Download
Enlivex (ENLV) Stock News & Sentiment
Download ENLV Report
Follow
532
Followers
Premium
Company Announcements
Enlivex Advances Allocetra Into Mid-Stage Knee Osteoarthritis Trial, Keeping Investor Focus on ENLV
16h ago
ENLV
Premium
Pre-Earnings
ENLV Earnings this Week: How Will it Perform?
24h ago
ENLV
Premium
Company Announcements
Enlivex Doses First U.S. Patient in Phase 2b Allocetra Trial for Knee Osteoarthritis
3d ago
6K
ENLV
Premium
Company Announcements
Enlivex Faces Nasdaq Minimum Bid Price Deficiency After Shares Fall Below $1 Threshold
5d ago
6K
ENLV
Premium
Market News
3 Best Cheap Stocks to Buy Now: 04/29/26
22d ago
ENLV
QUAD
Premium
Company Announcements
Enlivex Secures Danish Approval for Global Phase 2b Trial of Allocetra in Knee Osteoarthritis
30d ago
6K
ENLV
Premium
Company Announcements
Enlivex Shares Tokenized on Ondo Global Markets to Expand Global Digital Investor Access
1M ago
6K
ENLV
More ENLV News >
ENLV News on the Web
All News
Bearish News
Bullish News
2026-05-18
Enlivex Doses First U.S. Patient in Phase 2b Allocetra Trial for Knee Osteoarthritis
TipRanks News
Neutral
2026-05-18
Enlivex Therapeutics doses first patient in Allocetra trial
TipRanks News
Bullish
2026-05-15
Enlivex Faces Nasdaq Minimum Bid Price Deficiency After Shares Fall Below $1 Threshold
TipRanks News
Bearish
2026-04-29
3 Best Cheap Stocks to Buy Now: 04/29/26
TipRanks News
Neutral
2026-04-21
Enlivex Therapeutics files to sell 23.33M ordinary shares for holders
TipRanks News
Neutral
2026-04-21
Enlivex Secures Danish Approval for Global Phase 2b Trial of Allocetra in Knee Osteoarthritis
TipRanks News
Neutral
2026-04-21
Enlivex receives CTA approval by DKMA for Phase 2b trial of Allocetra
TipRanks News
Bullish
2026-04-08
Enlivex Shares Tokenized on Ondo Global Markets to Expand Global Digital Investor Access
TipRanks News
Neutral
150
Results | Showing
1
out of
19
News Score - Last 7 Days
Positive
ENLV
Sector Average
Media Buzz
This Week
5 articles
Weekly Average
1 articles
News Sentiment
This Week
67%
Sector Average
76%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is ENLV’s Media Buzz Sentiment?
5 articles about ENLV were published this week. In an average week, 1 articles are published.
What is ENLV’s weekly average amount of articles?
In an average week, 1 articles about ENLV are published.
What is ENLV’s News Sentiment?
67% of articles about ENLV were positive this week, compared to its sector average of 76%.
Healthcare Stocks that are Trending in the News
GOSS
Gossamer Bio
RLAY
Relay Therapeutics
CGEN
Compugen
ROIV
Roivant Sciences
PROK
ProKidney
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.